Ignite Creation Date:
2025-12-24 @ 7:57 PM
Ignite Modification Date:
2026-07-19 @ 7:39 AM
Study NCT ID:
NCT05776004
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-08
First Post:
2023-02-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia
Sponsor:
Eagle Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EGL-6535-C-2202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None